Caveolin-1 temporal modulation enhances trastuzumab and trastuzumab-drug conjugate efficacy in heterogeneous gastric cancer
Patrícia M. R. Pereira(Memorial Sloan Kettering Cancer Center), Jason S. Lewis(Memorial Sloan Kettering Cancer Center)
Cited by 0
Related Papers
1-<sup>11</sup>C-Acetate as a PET Radiopharmaceutical for Imaging Fatty Acid Synthase Expression in Prostate Cancer
|Journal of Nuclear Medicine|2008|154
Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-Trastuzumab
|PLoS ONE|2010|129
Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with <sup>18</sup>F-FDG and <sup>89</sup>Zr-Trastuzumab PET
|Journal of Nuclear Medicine|2013|93
Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer
|Nature Communications|2022|40